30 Day Trial

First U.S. Procedure with Cartiva Synthetic Cartilage Implant

Share:

The first commercial U.S. patient has received the Cartiva Synthetic Cartilage Implant following its FDA Premarket Approval for the treatment of great toe arthritis.

This article is a Member-only item of content. Members, please log in to read the complete post.
If you are not yet a Member, click here to learn more about purchasing ORTHOWORLD Membership.